Adenoviral expression of a urokinase receptor - Targeted protease inhibitor inhibits neointima formation in murine and human blood vessels

Circulation

Volumn 103, Issue 4, 2001, Pages 562-569

  Quax, Paul H A ^a,b,c,d   Lamfers, Martine L M ^a,b,c,d   Lardenoye, JanWillem H P ^a,b,c,d   Grimbergen, Jos M ^a,b,c,d   De Vries, Margreet R ^a,b,c,d   Slomp, Jennichjen ^a,b,c,d   De Ruiter, Marco C ^a,b,c,d   Kockx, Mark M ^a,b,c,d   Verheijen, Jan H ^a,b,c,d   Van Hinsbergh, Victor W M ^a,b,c,d  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Gene therapy; Plasminogen; Receptors; Restenosis; Urokinase

Indexed keywords

ALPHA 2 ANTIPLASMIN; APROTININ; HYBRID PROTEIN; PLASMIN; PLASMINOGEN ACTIVATOR; PROTEINASE INHIBITOR; UROKINASE RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BYPASS SURGERY; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTIMA; MOUSE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR BINDING; RESTENOSIS; SMOOTH MUSCLE FIBER; VIRUS EXPRESSION;

EID: 0035970094     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.4.562     Document Type: Article

References (32)

1. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury
2. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury
3. Smooth muscle migration in atherosclerosis and restenosis
4. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries
5. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by α(2)-macroglobulin receptor associated protein
6. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery
7. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
8. Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation: A gene targeting and gene transfer study in mice
9. Impaired arterial neointima formation in mice with disruption of the plasminogen gene
10. Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo
11. Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury
12. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins
13. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein
14. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice
15. Complementation between urokinase-producing and receptor- producing cells in extracellular matrix degradation
16. Inhibition of cell surface receptor-bound plasmin by α2-antiplasmin and α2-macroglobulin
17. Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding
18. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice
19. Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors
20. Cooperative effect of TNFα, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix: Role of urokinase activity
21. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type1 mRNA in rat tissues in vivo
22. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque
23. Intimal proliferation in an organ culture of human saphenous vein
24. Nature and origin of the neointima in whole vessel wall organ culture of the human saphenous vein
25. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA
26. Differential expression of α-6 and other subunits of laminin binding integrins during development of the murine heart
27. Gene therapy for vascular smooth muscle cell proliferation after arterial injury
28. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention
29. The modulation of smooth muscle cell phenotype is an early event in human aorto-coronary saphenous vein grafts
30. Remodeling of autologous saphenous vein grafts: The role of perivascular myofibroblasts
31. Wound healing around and within saphenous vein bypass grafts
32. Possible mechanisms of collar-induced intimal thickening